White matter changes in patients with Friedreich ataxia after treatment with erythropoietin

BACKGROUND AND PURPOSE: Erythropoietin (EPO) has received growing attention because of its neuro-regenerative properties. Preclinical and clinical evidence supports its therapeutic potential in brain conditions like stroke, multiple sclerosis and schizophrenia. Also in Friedreich ataxia, clinical im...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Egger, Karl, Clemm von Hohenberg, Christian, Schocke, Michael F, Guttmann, Charles RG, Wassermann, Demian, Wigand, Marlene C, Nachbauer, Wolfgang, Kremser, Christian, Sturm, Brigitte, Scheiber-Mojdehkar, Barbara, Kubicki, Marek, Shenton, Martha E, Boesch, Sylvia
Formato: Artigo
Idioma:Inglês
Publicado: 2013
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950637/
https://ncbi.nlm.nih.gov/pubmed/24015771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jon.12050
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares